Baricitinib for Depression in Male Football Players

JAK Signaling in Depression and Cognition in Male Football Players

Recruiting Phase 2 Interventional Study
Depressive Symptoms Cognitive Symptom
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 55
Sex
Male
Trial phase
Phase 2
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
Emory University · Other
Who this trial is looking for

This trial is looking for men aged 30-55 who have played tackle football for at least 11 years and are experiencing depression. Participants will take a medication called baricitinib to help understand its effect on their symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am male.
  • I have played tackle football for at least 11 years.
  • I am between 30 and 55 years old.
  • I have been diagnosed with major depression or bipolar, depressed type.
  • I have a PHQ-9 score over 10.
  • I am off all antidepressant medications for at least 4 weeks.
  • My CRP level is 3 mg/L or higher.
  • I have a score of 2 or more on specific PHQ-9 items.

You may not be able to join if

  • I have a current or past autoimmune disorder.
  • I have a history of hepatitis B or C, or HIV.
  • I have had cancer that needed more than minor surgery.
  • I have unstable heart, hormone, blood, liver, kidney, or brain disease.
  • I have a history of deep vein thrombosis.
  • I have had major surgery in the last 6 months.
  • I have an active or recent infection.
  • I have cirrhosis of the liver.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 11 years of organized tackle football. This will be evaluated using a medication called baricitinib, which blocks one aspect of inflammation.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * willing and able to give written informed consent * males * playing tackle football for at least 11 years * 30-55 years of age * Current Diagnostic and Statistical Manual (DSM)-V major depression or Bipolar, depressed type; or DSM-V major depression or Bipolar, depressed type …
Contacts

Andrew H Miller, MD

404-727-8260

amill02@emory.edu

CONTACT